University of Melbourne, Melbourne, VIC
University of Melbourne, Melbourne, VIC.
Med J Aust. 2018 Nov 19;209(10):455-460. doi: 10.5694/mja18.00142. Epub 2018 Oct 29.
Screening is an effective means for colorectal cancer prevention and early detection. Family history is strongly associated with colorectal cancer risk. We describe the rationale, evidence and recommendations for colorectal cancer screening by family history for people without a genetic syndrome, as reported in the 2017 revised Australian guidelines. Main recommendations: Based on 10-year risks of colorectal cancer, people at near average risk due to no or weak family history (category 1) are recommended screening by immunochemical faecal occult blood test (iFOBT) every 2 years from age 50 to 74 years. Individuals with moderate risk due to their family history (category 2) are recommended biennial iFOBT from age 40 to 49 years, then colonoscopy every 5 years from age 50 to 74 years. People with a high risk due to their family history (category 3) are recommended biennial iFOBT from age 35 to 44 years, then colonoscopy every 5 years from age 45 to 74 years. Changes in management as a result of the guidelines: By 2019, the National Bowel Cancer Screening Program will offer all Australians free biennial iFOBT screening from age 50 to 74 years, consistent with the recommendations in these guidelines for category 1. Compared with the 2005 guidelines, there are some minor changes in the family history inclusion criteria for categories 1 and 2; the genetic syndromes have been removed from category 3 and, as a consequence, colonoscopy screening is now every 5 years; and for categories 2 and 3, screening begins with iFOBT for people aged 40 and 35 years, respectively, before transitioning to colonoscopy after 10 years.
筛查是预防和早期发现结直肠癌的有效手段。家族史与结直肠癌风险密切相关。我们描述了 2017 年修订的澳大利亚指南中针对无遗传综合征人群的家族史结直肠癌筛查的原理、证据和建议。主要建议:基于 10 年结直肠癌风险,无家族史或家族史较弱(1 类)的人群被推荐从 50 岁至 74 岁每 2 年进行免疫化学粪便潜血试验(iFOBT)筛查。由于家族史而具有中度风险(2 类)的个体被推荐从 40 岁至 49 岁每 2 年进行 iFOBT 筛查,然后从 50 岁至 74 岁每 5 年进行结肠镜检查。由于家族史而具有高风险(3 类)的人群被推荐从 35 岁至 44 岁每 2 年进行 iFOBT 筛查,然后从 45 岁至 74 岁每 5 年进行结肠镜检查。指南变化:到 2019 年,国家结直肠癌筛查计划将为所有 50 岁至 74 岁的澳大利亚人提供免费的每 2 年 iFOBT 筛查,与这些指南中对 1 类人群的建议一致。与 2005 年指南相比,1 类和 2 类人群的家族史纳入标准略有变化;3 类人群已不再包括遗传综合征,因此结肠镜检查现在每 5 年进行一次;对于 2 类和 3 类人群,iFOBT 筛查从 40 岁和 35 岁开始,10 年后过渡到结肠镜检查。